As the COVID-19 epidemic waned and companies got back to business as usual, SmartTRAK continued to keep you informed of everything that transpired in the MedTech industry in 2022. Here are SmartTRAK's Top 10 blog posts of the past year that garnered the most attention from you and your colleagues, plus 4 bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!

As the leading provider of real-time market data and analysis for the orthopedic, wound, regenerative medicine and neuro therapies markets, SmartTRAK is uniquely suited to make you the expert on all the latest developments. Our knowledgeable analysts covered a lot of ground, everything from breaking medical device event coverage to interviews with some of the industry's top thought leaders.

Medtronic: The Future of Neuromodulation in 2022 and Beyond
by Anne Staylor

Dave Anderson, Medtronic’s President Neuromodulation, and Charlie Covert, Vice President and General Manager of Pain Therapies, discuss the Company, the pandemic and the future of neuromodulation in a wide-ranging interview with SmartTRAK.

SmartTRAK, the leading global Medtech business and market insights platform in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, announces the expansion of its solutions portfolio focused on new market coverage for Wound Debridement and Injectables for spinal disc degeneration and osteoarthritis (OA) of the knee.

SmartTRAK is an Insights-as-a-Service platform that equips customers with real-time, accurate market, company and product insights from hundreds of carefully curated data sources. The solution includes rich content provided through a SaaS platform and includes daily updates, tools and dashboards along with direct access to market analysts and expert advisory services.

Wound Debridement, a newly covered segment offered on the SmartTRAK platform, is foundational to wound healing and the success of every advanced wound care product. According to Wound Care market expert and General Manager Gary Delhougne, “our new module will cover the full scope of the debridement market opportunity and will be beneficial to companies directly participating or contemplating entering into the debridement space.” The Wound Debridement module is now widely available to customers.

SmartTRAK is pleased to announce that Joe Mish has been named new VP of Sales and will lead our commercial team. Before joining SmartTRAK two years ago, originally as Director of Sales, Joe had 10+ years experience in medical device sales, with a concentration on Joint Replacement and Spine & Robotic Technologies. Joe sold and implemented analytic software to manage value-based care and bundled payment, working with Stryker, LDR/ZimmerBiomet and Stryker Performance Solutions.

"I couldn't be more pleased to have a true professional with data analytics/IT/SaaS plus medical device background like Joe in this position. I think you will agree that he is the right person to bring SmartTRAK to the next level." - SmartTRAK CEO Sharon O'Reilly

Meet Joe Mish, SmartTRAK's new VP of Sales: 

What do you like about SmartTRAK? I truly love the value we bring to our customers. With the world being so volatile and medical device markets still being disrupted in so many ways, we offer clients a predictable way to stay ahead of their competition. This is extremely rare. There is no better feeling than standing behind a company and product that you really believe in…we are focused and committed to building long term relationships and strategic partnerships with our customers, and it shows.

• See gaps in your product portfolio vs your competitors’ 
• Discover your next acquisition candidate
• Find a distribution partner

…in just a few clicks!

BE THE EXPERT who fills in the gaps in your company's portfolio! Read on to view a "How To" video and learn how to outperform your peers and competitors by saving yourself HOURS of research with just ONE search.

That’s the power of SmartTRAK!

For example…

Are you looking for a position that gives you a big picture view of everything that is going on in the world of life sciences? Do you have business experience in the medical device industry? If so, we would love to talk with you.

We are BioMedGPS, the creators of the SmartTRAK platform. We are the leading strategic advisory and healthcare analytics provider in the life sciences industry. Our team is once again expanding and seeking an Account Manager who can grow with us. The Account Manager will be responsible for creating and maintaining strategic relationships with our medical device clients.

SmartTRAK, the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies, was once again cited as a trusted source, this time in ConvaTec's press release "Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc" published January 28th.

ConvaTec, in the press release, stated that it was " ...

Despite the seemingly never-ending COVID-19 epidemic, SmartTRAK continued to keep you informed of everything that transpired in the MedTech industry in 2021. As the leading provider of real-time market data and analysis for the orthopedic, wound, regenerative medicine and neuro therapies markets, SmartTRAK is uniquely suited to make you the expert on all the latest developments. Our knowledgeable analysts covered a lot of ground, everything from breaking medical device event coverage to interviews with some of the industry's top thought leaders.

Here are SmartTRAK's Top 10 blog posts of the past year that garnered the most attention from you and your colleagues, plus 3 bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!

Trends in OrthoBiologics & Regenerative Medicine: A Surgeon's Perspective
by Freddy Buntoum

In this wide-ranging interview with SmartTRAK, Dr. Wasik Ashraf, an Orthopaedic Surgeon specializing in Sports Medicine, gives his view of CMS' FY21 OPPS-ASC Final Rulemaking, and discusses emerging trends and innovation in OrthoBiologics and Regenerative Medicine.

SmartTRAK highlights what’s new in orthopedics, sports medicine, wound care, regenerative medicine and neuro therapies, with a spotlight on Depuy Synthes, a subsidiary of J&J. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, research, financial data and competitor developments in the global life sciences industry.

The following is a sampling of some recent updates covering Depuy Synthes that were compiled, reviewed and posted in real-time by our SmartTRAK analysts.

New Products:

• DePuy Synthes will distribute Expanding Innovations’ X-Pac Expandable Lumbar Cage System in the US. The system allows for controlled expansion of both height and lordosis and post-packing of graft.
• In its Q420 earnings call, JNJ touted the FDA clearance of its VELYS Robotic-Assisted Solution for use w/ the ATTUNE* knee system. The Company will launch its VELYS robot for TKA in 2021, however, specific timing was not provided. JNJ Q420 Earnings Transcript on Seeking Alpha
• WFS analyst Larry Biegelsen notes that in addition to competitive advantages including small footprint, digital connectivity, short set-up time & small learning curve, JNJ’s VELYS robot is expected to be cost-effective w/ prior commentary suggesting a price point of ~$250K.
  
  

Sure you read the news, a blog or journal or two, but you do you ever truly feel like you know what your competition is up to? SmartTRAK does! We provide real-time market intel on the MedTech industry including trends, news, financial data, competitor developments and more.  Our platform is fueled by industry experts, all of whom have had years of previous experience working at some of the biggest players in the industry.  Our team knows what's important to you and we keep our eye to the competition 24/7-- so that our subscribers can save time and find all the competitive intel they need in one place.

SmartTRAK currently features profiles on an ever-growing growing list of over 7,000+ products, including product descriptions, classifications, indications, clinical updates, regulatory status, studies, reimbursements, sales and distribution and more. Learn more about SmartTRAK's competitor profiling below:

SmartTRAK also provides up-to-date, detailed company overviews, including the latest intel, revenues and financial outlooks, strategic alliances and more on over 1,100+ companies, and the list is growing daily. New to a particular industry, or looking to expand into new territory? SmartTRAK's company and product profiles can help you get the lay of the land quickly: